Literature DB >> 4074610

Contrasts between pindolol and propranolol concentration-response relationships.

S G Carruthers, W L Pacha, W H Aellig.   

Abstract

The plasma concentration-response relationships of oral and intravenous pindolol and propranolol have been studied in a group of eight healthy male subjects who received each dosage form in a randomized single-blind cross-over manner. Despite similar elimination half-lives, the duration of action of pindolol was longer than that of propranolol. This longer duration of action was associated with a flatter concentration-response curve for pindolol and may be related to the partial agonist activity of pindolol. Propranolol concentration-response curves were dependent on the route of drug administration whereas pindolol curves were similar following oral and intravenous routes of administration.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4074610      PMCID: PMC1400882          DOI: 10.1111/j.1365-2125.1985.tb05088.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  17 in total

1.  [Clinicopharmacological studies with pindolol following intravenous and oral administration].

Authors:  W H Aellig
Journal:  Adv Clin Pharmacol       Date:  1976

2.  Spuriously low plasma propranolol concentrations resulting from blood collection methods.

Authors:  R H Cotham; D Shand
Journal:  Clin Pharmacol Ther       Date:  1975-11       Impact factor: 6.875

3.  Effect of route of administration on the relationship between -adrenergic blockade and plasma propranolol level.

Authors:  C R Cleaveland; D G Shand
Journal:  Clin Pharmacol Ther       Date:  1972 Mar-Apr       Impact factor: 6.875

4.  Pharmacokinetics of unlabelled and 14C-labelled pindolol in uraemia.

Authors:  E E Ohnhaus; E Nüesch; J Meier; F Kalberer
Journal:  Eur J Clin Pharmacol       Date:  1974       Impact factor: 2.953

5.  Pharmacological analysis of beta-adrenoceptor-mediated agonism in the guinea-pig, isolated, right atrium.

Authors:  J W Black; V P Gerskowitch; P Leff; N P Shankley
Journal:  Br J Pharmacol       Date:  1985-03       Impact factor: 8.739

6.  Diminishing hypotensive effect of increasing doses of pindolol in DOCA/saline hypertensive rats.

Authors:  R E Buckingham; T C Hamilton; D Robson
Journal:  Br J Pharmacol       Date:  1978-03       Impact factor: 8.739

7.  Influence of intrinsic sympathomimetic activity and cardioselectivity on beta adrenoceptor blockade.

Authors:  D G McDevitt; H C Brown; S G Carruthers; R G Shanks
Journal:  Clin Pharmacol Ther       Date:  1977-05       Impact factor: 6.875

8.  A method for the fluorimetric determination of 4-(2-hydroxy-3-isopropylaminopropoxy)-indole (LB46), a beta-blocking agent, in plasma and urine.

Authors:  W L Pacha
Journal:  Experientia       Date:  1969-08-15

9.  beta-Adrenoceptor blocking activity and duration of action of pindolol and propranolol in healthy volunteers.

Authors:  W H Aellig
Journal:  Br J Clin Pharmacol       Date:  1976-04       Impact factor: 4.335

10.  Pharmacology of 4-hydroxypropranolol, a metabolite of propranolol.

Authors:  J D Fitzgerald; S R O'Donnell
Journal:  Br J Pharmacol       Date:  1971-09       Impact factor: 8.739

View more
  1 in total

1.  Circadian influence on effect of propranolol on exercise-induced tachycardia in healthy subjects.

Authors:  A Fujimura; Y Kumagai; K Sugimoto; H Nakashima; H Kajiyama; A Ebihara; K Ohashi
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.